PRESS RELEASE published on 09/12/2025 at 07:30, 1 year ago Inside Information / Other news releases Medincell appoints Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon to its Board of Directors, adding valuable expertise in biotech and pharmaceutical sectors Board Of Directors Medincell Dr. Sharon Mates Dr. Charles Kunsch Dr. Pascal Touchon
BRIEF published on 09/10/2025 at 21:46, 1 year ago UZEDY® Obtains Approval in South Korea Following Success in the United States Schizophrenia UZEDY Teva Handok Medical Supply Korean Market
BRIEF published on 09/10/2025 at 21:46, 1 year ago UZEDY® obtient l'approbation en Corée du Sud après son succès aux États-Unis Schizophrénie UZEDY Approvisionnement Médical Teva Handok Marché Coréen
PRESS RELEASE published on 09/10/2025 at 21:41, 1 year ago Informations privilégiées / Autres communiqués UZEDY(R) approuvé en Corée du Sud après un lancement réussi aux États-Unis. Medincell percevra des royalties sur les ventes et est éligible à des milestones commerciaux Schizophrénie Approbation Medincell Corée Du Sud UZEDY
PRESS RELEASE published on 09/10/2025 at 21:41, 1 year ago Inside Information / Other news releases Teva Handok announces regulatory approval for UZEDY® in South Korea by Ministry of Food and Drug Safety, following successful US launch. Medincell's long-acting injectable for schizophrenia shows strong commercial performance Regulatory Approval Schizophrenia Medincell Commercial Performance Teva Handok
BRIEF published on 08/04/2025 at 14:05, 1 year 1 month ago Medincell Annonce son Assemblée Générale 2025 Gouvernance Assemblée Générale Resolutions Medincell Rémunérations
BRIEF published on 08/04/2025 at 14:05, 1 year 1 month ago Medincell Announces its 2025 General Meeting Governance General Meeting Resolutions Remuneration Medincell
PRESS RELEASE published on 08/04/2025 at 14:00, 1 year 1 month ago Informations privilégiées / Autres communiqués Medincell publie la convocation pour son assemblée générale annuelle mixte 2025, incluant des résolutions sur les comptes, l'approbation des dirigeants et des délégations au Conseil d'administration Assemblée Générale Convocation Resolutions Pharmaceutique Medincell
BRIEF published on 07/30/2025 at 14:34, 1 year 1 month ago Medincell's Rising Revenue and Upcoming Submissions Schizophrenia Treatment Teva Partnership Medincell Revenue UZEDY Sales Olanzapine Submission
BRIEF published on 07/30/2025 at 14:34, 1 year 1 month ago Chiffre d'affaires croissant de Medincell et prochaines soumissions Traitement De La Schizophrénie Chiffre D'affaires De Medincell Ventes UZEDY Soumission D'olanzapine Partenariat Teva
Published on 09/26/2026 at 01:00, 1 day 19 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 22 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 3 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 5 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 3 hours 40 minutes ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 5 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 5 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 5 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 13 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 3 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 3 hours ago Availability of the 2026 half-year financial report